`
`, srieate
`
`-
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`
`AGdress: COMMISSIONER FOR PATENTS
`Alexanuitia, Virginia 27313-1430
`
` wee.Oat.uOY
`
`
`EYL PEE REC'D
`PPOT CLAMMS FIND CLAIMS
`
`
`1660
`
`:
`
`I
`
`TENDS,185
`il
`3537.FSSAC
`CONFIRMATION NO. 2363
`26111
`vrei hice RRR ARES RE
`HGR
`RRL
`ARE
`
` STEFINEKESSLER, GOLDSTEIN & FOX PL. oe
`
`10th Floor
`WASHINGTON, DG 20005
`
`Date Mailed: 68/1 0/2023
`
`Receipt is acknowledged of ihis non-provisional utility patent application. The application will be taken up for
`examination in due course. Applicant will be notified as to the results of the examination. Any corresponderice
`concerning the application must include the following identification information: the ULS. APPLICATION NUMBER,
`FILING DATE, NAME OF FIRST INVENTOR, and TITLE OF INVENTION. Fees transmitied by check or draft are
`subject to collection.
`
`Please verily the accuracy of the data presented an this receipt. If an error is noted on this Filing Receipt, please
`submit a written request for a corrected Filing Receipt, including a properly marked-up ADS showing ihe changes
`with strike-through for deletions and underlining for additions. H you received a "Notice to File Missing Parts” o1
`other Notice requiring a response for this application, please submit any requesi for correction to ihis Filing Receipt
`with your reply to the Notice. When the USPTO processes the reply to the Notice, the USPTO will generate another
`Filing Receipt incorporating the requesied corrections providecthat the request is grantabie.
`
`Inventor(s)
`
`Hidekazu Masaki, Saitarna City, Saitama, JAPAN;
`Shigeturni KUMACHI, Salama City, Saitama, JAPAN;
`Ryo YONEHARA, Saitama City, Saitama, JAPAN:
`Yula MATSUMURA, Yokohama-shi, Kanagawa, JAPAN;
`Hibkki KAWANO, Ota-ku, Tokyo, JAPAN:
`Takuto TOJO, Wakayama-shi, Wakayama, JAPAN:
`Takuya MORIMOTO, Ota-ku, Tokyo, JAPAN:
`Kazunhika KATAYAMA, Minato-ku, Tokyo, JAPAN:
`Kel HAGA, Minato-ku, Tokyo, JAPAN;
`Reiko TODAKA, Minato-ku, JAPAN:
`Akinito SAWADA, Minato-ku, Tokyo, JAPAN:
`Tomaomi TAKANG, Towada-shi, Aomori, JAPAN:
`
`Applicant(s}
`
`EPSILON MOLECULAR ENGINEERING, INC., Saitama City, Saitama, JAPAN;
`THE KITASATO INSTITUTE, Minato-ku, Tokyo, JAPAN:
`Kao Carporalion, Chuo-ku, Tokyo, JAPAN:
`Assignment For Published Patent Application
`EPSILON MOLECULAR ENGINEERING, INC., Saitama City, Saitama, JAPAN
`THE KITASATO INSTITUTE, Minato-ku, Tokyo, JAPAN
`Kao Corporation, Chuo-ku, Tokyo, JAPAN
`
`Power of Attorney: The patent practitioners associated with Customer Number 26711
`
`page 1 af 4
`
`

`

`Domestic Priority data as claimed by applicant
`This application is a 371 of POT/UP2021/036446 70/01/2021
`
`
`JAPAN
`
`Foreign Applications (You may be eligible fo benef from the Patent Prosecution Highway programal the
`USPTO. Please see hitp:/Avww usolo.gov far more information.)
`JAPAN 2020-168078 10/02/2026 No Access Code Provided
`Ades 020-1 85268 11/05/2020 No Access Code Provided
`JAPAN 2020-201212 12/03/2020 No Access Code Provided
`JAPAN 2027 -G85698 05/20/2021 No Access Code Provided
`JAPAN 2021-134372 08/19/2021 No Access Code Provided
`JAPAN 2021-150604 09/15/2021 No Access Code Provided
`
`Permission to Access Application via Priority Document Exchange: Yes
`
`Permission to Access Search Resulis: Yes
`
`Applicant may provide or rescind an authorization for access using Form PTO/SB/39 or Form PTO/SB/69 as
`appropriate.
`
`if Required, Forelgn Filing License Granted: 08/09/2023
`
`The country code and number of your priority application, to be used for filling abroad under the Paris Convention,
`is US 18/028,185
`
`Projected Publication Date: 11/18/2023
`
`Non-Publication Request: No
`
`Early Publication Request: No
`Title
`
`SARS-COV-2-BINDING PEPTIDE
`
`Preliminary Class
`
`Statement under 37 CFR 1.55 or 1.78 for ALA (First Inventor to File} Transition Applicatians: No
`
`PROTECTING YOUR INVENTION OUTSIDE THE UNITED STATES
`
`Since the rights granted by a U.S. patent extend only throughout ihe territory of the United States and have no
`effect in a ioreign country, an inventor who wishes patent protection in another country must apply for a patent
`in. @ specific country or in regional patent offices. Applicanis may wish to consider the filing of an international
`application under the Patent Cooperation Treaty (PCT). An international (PCT) application generally has ihe same
`effect as a regular national patent application in each PCT-member country. The PCT pracess simplifies the filing
`of patent applications on the same invention in member countries, bul dees not resull in a grant of "an international
`patent” and does not eliminate the need of applicants fo file acidlitiona! documents and fees in countries where patent
`protection is desired.
`
`Almost every country has its own patent law, and @ person desiring a patent in a particular country must make an
`application for patent in that country in accordance with its particular jaws. Since the laws of many countries differ
`in various respects from the patent law of the United States, applicanis are advised io seek quidance from specific
`foreign countries to ensure that patent rights are nat lost prematurely.
`
`page 2 at 4
`
`

`

`Applicants also are advised that in the case of inventions made in the United States, the Director of the USPTO must
`issue a Heense before applicants can apply fer a patent in a foreign country. The fillng of a US. patent application
`serves as a request for a foreign filing license. The application's fling receipt contains further information and
`guidances as fo the status of applicant's license for foreign filing.
`
`Applicanis may wish to consull the USPTO bookiel, “General infarmation Concerning Patents" (specifically, the
`section entitled "Treaties and Foreign Patents’) for more information on timeframes and cleadiines for fling foreign
`patent applications. The guide is available either by contacting the USPTO Contact Center at 800-786-9199, orit
`can be viewed on the USPTO website at htte:/Awww.uspio.gov/web/offices/pac/doc/general/index. nimi.
`
`For information on preventing theft of your intellectual property (patents, trademarks and copyrights}, you may wish
`to consult the U.S. Government website, htto/Avww.stopfakes.gov. Part of a Depariment of Cornmerce initiative,
`this website includes self-help “toolkits” giving Innovators guidance on hawto protect intellectual properiy in speerfic
`countries such as China, Korea and Mexico. For questions regarding patent enforcement issues, applicants may
`call the US. Government hotline at 1-866-999-HALT (4-866-999-4258),
`
`LICENSE FOR FOREIGN FILING UNDER
`
`Title 35, United States Code, Section 1984
`
`Title 37, Code of Federal Regulations, 5.11 & 5.75
`
`GRANTED
`
`if the phrase "IF REQUIRED, FOREIGN FILING
`The applicant has bean granted a Jicense under 35 U.S.C. 184,
`LIGENSE GRANTED"followed by a date appears on this form. Such licenses are issued in all applications where
`the conditions for issuance of a license have been met, regardless of whether or nat a license may be required as
`sei forth in $7 CFR 5.75. The scope and limitations of this license are sei forth in 37 CFR 5.75(a) unless an earlier
`license has been issued under 37 CFR 5.15(b). The license is subject to revocation upon written notification. The
`date indicated is the effective daie af the license, unless an earlier license of similar scope has been granted under
`37 CFR 5.73 of 5.14
`
`This heense is ta be retained by the licensee and may be used at anytime onor alter the effective date thereof unless
`itis revoked. This license is automatically transferred to any related applications(s) fled under 37 CFR 1.53{cd)}. This
`license is not retroactive.
`
`The grant of a license does not in any way lessen the responsibility of a licensee far the security ofthe subject matter
`as imposed by any Government contract or the provisions of existing jaws relating to espionage and the national
`security or the export of technical daia. Licensees should apprise themselves of current requilations especially with
`respect to certain countries, of other agencies, particularly the Office of Defense Trade Controls, Department of
`State (with respect to Arms, Munitions and Implements of War (22 CFR 121-1283): the Bureau of Industry and
`Securly, Department of Commerce (15 CFR parts 730-774); the Office of Foreign AssetsControl, Department of
`Treasury (1 GFR Parts 5004} and the Depariment of Energy.
`
`NOT GRANTED
`
`No license under 35 LLS.C. 184 has been granted at this time, if ihe phrase "IF REQUIRED, FOREIGN FILING
`LICENSE GRANTED” DOES NOT appear on this form. Applicant may still petition for a license under 37 CFR 5.712,
`if a teense is desired before the expiration of 6 manths fram the fing date of ihe application. If 6 months has lapsed
`
`page 3 af 4
`
`

`

`frorn the filing date of this application and the licensee has not received anyindication of a secrecy order under 35
`U.S.C. 181, the licensee may foreignfile the application pursuant io 37 CFR 5.15(b).
`
`SelectliSa
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled locationfor
`business investment, innovation, and commercialization of naw technologies. The U.S. offers
`tramencaus resources
`and advantages for those who invest and manufacture goods hers. Through SelectliSA, our nation works fo
`promote and facilitate business invesiment. SelectUSA provides information assistance to the international investor
`community: serves as an ombudsmanfor existing and potential investors; advocates on behalf of U_S. cities, states,
`and regions competing for global investment; and counsels U.S. economic development organizations on invesiment
`attraction best practices. To learn more about why the United States is the best country in the world to develop
`technology, manufacture products, deliver services, and grow your business, visit httpv/Avww.SelectliSA. govor cail
`+1-202-482-6800.
`
`page 4 af 4
`
`